Green Light from FDA for the Launch of Estelle®(E4/DRSP) Phase III Study in the United States

  • Mithra obtains FDA’s approbation for its Investigational New Drug for the Phase III clinical trials of Estelle® (E4/DRSP).
  • This green light paves the way for the clinical trial of Mithra’s Estetrol-based product candidate in contraception in the United States and in Canada.

Read the press release